CTSB and psoriasis: Cysteine protease inhibitors treatment significantly decreased psoriasis area and severity index (PASI) compared to the untreated group (Figures 1A, B), with a more prominent effect observed from day 3 onwards in the case of Sialostatin L and Sialostatin L2.